홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1,1'-Carbonyldiimidazole → ethyl (5R)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinecarboxylate

HRID 1826204
인쇄

반응식

HRID 1826204 반응식
[F:1][C:2]1[CH:3]=C(C=[CH:7][C:8]=1[N:9]1[CH2:14][CH2:13][O:12][CH2:11][CH2:10]1)N.[O:15]1C[C@@H:16]1[C:17]([O:19][CH2:20][CH3:21])=[O:18].[O-]S(C(F)(F)F)(=O)=O.[Li+].[C:32]([N:39]1[CH:43]=[CH:42]N=[CH:40]1)(N1C=CN=C1)=[O:33]>C(#N)C>[F:1][C:2]1[CH:3]=[C:43]([N:39]2[CH2:40][C@H:16]([C:17]([O:19][CH2:20][CH3:21])=[O:18])[O:15][C:32]2=[O:33])[CH:42]=[CH:7][C:8]=1[N:9]1[CH2:10][CH2:11][O:12][CH2:13][CH2:14]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 682631,1'-CarbonyldiimidazoleHCID 14853303-Fluoro-4-morpholinoanilineHCID 1512667ethyl (2R)-oxirane-2-carboxylateHCID 3664839Trifluoromethanesulfonic acid, lithium salt

생성물 1

HCID 86590830ethyl (5R)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinecarboxylate

시약·촉매·용매 1

HCID 6342
Acetonitrile
용매

실험 절차

A solution of 3-fluoro-4-morpholinoaniline (J. Med. Chem. 1996, 39(3), 673-679, 0.796 g, 4.0 mmol), ethyl 2(R)-epoxypropanoate (0.696 g, 6.0 mmol) and lithium triflate (0.97 g, 6.2 mmol) in acetonitrile (12 mL) was stirred at 50-60° C. overnight. Solvent and excess epoxide was removed under reduced pressure, and the crude amino alcohol was redissolved in dry acetonitrile (40 mL) and 1,1′-carbonyldiimidazole (1.46 g, 9.0 mmol) was added. The mixture was stirred at ambient temperature overnight, and then the solvent was removed under reduced pressure. The residue was partitioned between ethyl acetate (70 mL) and 3% aqueous citric acid (100 mL), the layers are separated, and the organic phase was washed with 3% aqueous citric acid (3×100 mL), water and saline, dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The product mixture was then purified by silica gel chromatography, eluting with ethanol/methylene chloride (2/98), and the appropriate fractions are pooled and concentrated to give the title compound, MS (ESI+) for C16H19N2O5F m/z 339 (M+H)+.

후처리

  1. customSolvent and excess epoxide was removed under reduced pressure
  2. dissolutionthe crude amino alcohol was redissolved in dry acetonitrile (40 mL)
  3. customthe solvent was removed under reduced pressure
  4. customThe residue was partitioned between ethyl acetate (70 mL) and 3% aqueous citric acid (100 mL)
  5. customthe layers are separated
  6. washthe organic phase was washed with 3% aqueous citric acid (3×100 mL), water and saline
  7. dry with materialdried over anhydrous magnesium sulfate
  8. concentrationconcentrated under reduced pressure
  9. customThe product mixture was then purified by silica gel chromatography
  10. washeluting with ethanol/methylene chloride (2/98)
  11. concentrationconcentrated

출처 및 근거

ORD 기록
ord-fdf6e3ea18aa40a2b533d2228ec844db
출처 데이터셋
uspto-grants-2006_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07049443B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트